Lung cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study

Cancer

Volumn 123, Issue , 2017, Pages 5079-5099

  Richards, Thomas B ^a   Henley, S Jane ^a   Puckett, Mary C ^a   Weir, Hannah K ^a   Huang, Bin ^b   Tucker, Thomas C ^b   Allemani, Claudia ^c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

cancer registries; disparities; lung neoplasms; population based survival; race; stage; survival; trends

Indexed keywords

ADULT; AGED; ARTICLE; BLACK PERSON; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES; ADOLESCENT; AFRICAN AMERICAN; EPIDEMIOLOGY; ETHNOLOGY; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; REGISTER; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES; UNITED STATES; YOUNG ADULT;

EID: 85037614941     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.31029     Document Type: Article

References (51)

1. US Cancer Statistics (USCS) Working Group. US Cancer Statistics: 1999-2013 Incidence and Mortality Web-Based Report. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Cancer Institute; 2016. Available at: www.cdc.gov/uscs. Accessed May 9, 2017.
2. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2014, based on November 2016 SEER data submission, posted to the SEER web site, April 2017. Bethesda, MD: National Cancer Institute; 2017. Available at: https://seer.cancer.gov/csr/1975_2014/. Accessed May 9, 2017.
3. Weir HK, Thompson TD, Soman A, Moller B, Leadbetter S. The past, present, and future of cancer incidence in the United States: 1975 through 2020. Cancer. 2015;121:1827-1837.
4. Weir HK, Thompson TD, Soman A, Moller B, Leadbetter S, White MC. Meeting the Healthy People 2020 objectives to reduce cancer mortality [serial online]. Prev Chronic Dis. 2015;12:E104.
5. Weir HK, Stewart S, Allemani C, et al. Population-based cancer survival (2001-2009) in the United States: findings from the CONCORD-2 study. Cancer. 2017;123:4963-4968.
6. Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2) [and Supplemental Web Table 4]. Lancet. 2015;385:977-1010.
7. Allemani C, Harewood R, Johnson CJ, et al. Population-based cancer survival in the United States: data, quality control, and statistical methods. Cancer. 2017;123:4982-4993.
8. White MC, Babcock F, Hayes NS, et al. The history and use of cancer registry data and public health cancer control programs in the United States. Cancer. 2017;123:4969-4976.
9. Fritz AG, Percy C, Jack A, et al, eds. International Classification of Diseases for Oncology (ICD-O). 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
10. Young JL, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA. SEER Summary Staging Manual-2000: Codes and Coding Instructions. NIH Pub. No. 01-4969. Bethesda, MD: National Cancer Institute; 2001.
11. National Cancer Institute; Surveillance, Epidemiology, and End Results Program. Collaborative Stage. Bethesda, MD: National Cancer Institute; 2004. Available at: http://seer.cancer.gov/tools/collabstaging/. Accessed May 9, 2017.
12. Pohar Perme M, Stare J, Esteve J. On estimation in relative survival. Biometrics. 2012;68:113-120.
13. Rachet B, Maringe C, Woods LM, Ellis L, Spika D, Allemani C. Multivariable flexible modelling for estimating complete, smoothed life tables for sub-national populations [serial online]. BMC Public Health. 2015;15:1240.
14. Spika D, Bannon F, Bonaventure A, et al. Life tables for global surveillance of cancer survival (the CONCORD programme): data sources and methods. BMC Cancer. 2017;17:159.
15. Corazziari I, Quinn MJ, Capocaccia R. Standard cancer patient population for age standardizing survival ratios. Eur J Cancer. 2004;40:2307-2316.
16. Quaresma M, Coleman MP, Rachet B. Funnel plots for population-based cancer survival: principles, methods and applications. Stat Med. 2014;33:1070-1080.
17. Henley SJ, Singh SD, King J, Wilson RJ, O'Neil ME, Ryerson AB. Invasive cancer incidence and survival—United States, 2012. MMWR Morb Mortal Wkly Rep. 2015;64:1353-1358.
18. Momin BR, Pinheiro PS, Carreira H, Li C, Weir HK. Liver cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123:5059-5078.
19. Jim MA, Pinheiro PS, Carreira H, Espey DK, Wiggins CL, Weir HK. Stomach cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123:4994-5013.
20. Stewart SL, Harewood R, Matz M, et al. Disparities in ovarian cancer survival in the United States (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123:5138-5159.
21. Benard V, Watson M, Saraiya M, et al. Cervical cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123:5119-5137.
22. Joseph DA, Johnson CJ, White A, Wu M, Coleman MP. Rectal cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123:5037-5058.
23. White A, Joseph DA, Rim SH, Johnson CJ, Coleman MP, Allemani C. Colon cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123:5014-5036.
24. Tai E, Ward K, Bonaventure A, Siegel D, Coleman MP. Survival among children diagnosed with acute lymphoblastic leukemia in the United States by race and age, 2001 to 2009: findings from the CONCORD-2 study. Cancer. 2017;123:5178-5189.
25. Miller JW, Lee Smith J, Ryerson AB, et al. Disparities in breast cancer survival in the United States (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123:5100-5118.
26. Steele CB, Li J, Huang B, Weir HK. Prostate cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123:5160-5177.
27. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341:1198-1205.
28. Lathan CS, Neville BA, Earle CC. The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol. 2006;24:413-418.
29. Nadpara P, Madhavan SS, Tworek C. Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: a population-based study. Cancer Epidemiol. 2015;39:1136-1144.
30. Lathan CS. Lung cancer care: the impact of facilities and area measures. Transl Lung Cancer Res. 2015;4:385-391.
31. Haider AH, Dankwa-Mullan I, Maragh-Bass AC, et al. Setting a national agenda for surgical disparities research: recommendations from the National Institutes of Health and American College of Surgeons Summit. JAMA Surg. 2016;151:554-563.
32. Lathan CS, Waldman LT, Browning E, Gagne J, Emmons K. Perspectives of African Americans on lung cancer: a qualitative analysis. Oncologist. 2015;20:393-399.
33. Vest MT, Herrin J, Soulos PR, et al. Use of new treatment modalities for non-small cell lung cancer care in the Medicare population. Chest. 2013;143:429-435.
34. Chen AB, Li L, Cronin A, Schrag D. Comparative effectiveness of intensity-modulated versus 3D conformal radiation therapy among Medicare patients with stage III lung cancer. J Thorac Oncol. 2014;9:1788-1795.
35. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Non-Small Cell Lung Cancer. Version 3. Fort Washington, PA: NCCN; 2017. Available at: http:www.nccn.org. Accessed May 9, 2017.
36. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG, eds; International Agency for Research on Cancer. WHO Classification of Tumours of the Lung, Pleura, Thymus, and Heart. 4th ed. Geneva, Switzerland: World Health Organization; 2015.
37. Brawley OW. Lung cancer and race: equal treatment yields equal outcome among equal patients, but there is no equal treatment. J Clin Oncol. 2006;24:332-333.
38. Cho H, Mariotto AB, Schwartz LM, Luo J, Woloshin S. When do changes in cancer survival mean progress? The insight from population incidence and mortality. J Natl Cancer Inst Monogr. 2014;2014:187-197.
39. Moyer VA; US Preventive Services Task Force. Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:330-338.
40. Centers for Medicare and Medicaid Services (CMS). Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG-00439N). Baltimore, MD: CMS; 2015. Available at: https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274. Accessed May 9, 2017.
41. The National Academies of Sciences, Engineering, and Medicine. Implementation of Lung Cancer Screening: Proceedings of a Workshop. Washington, DC: The National Academies Press; 2016. Available at: http://www.nap.edu/23680. Accessed May 9, 2017.
42. Major A, Stewart SL. Celebrating 10 years of the National Comprehensive Cancer Control Program, 1998 to 2008 [serial online]. Prev Chronic Dis. 2009;6:A133.
43. US Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
44. Neri A, Stewart SL, Angell W. Radon control activities for lung cancer prevention in national comprehensive cancer control program plans, 2005-2011 [serial online]. Prev Chronic Dis. 2013;10:E132.
45. Richards TB, White MC, Caraballo RS. Lung cancer screening with low-dose computed tomography for primary care providers. Prim Care. 2014;41:307-330.
46. Dunne K, Henderson S, Stewart SL, et al. An update on tobacco control initiatives in comprehensive cancer control plans [serial online]. Prev Chronic Dis. 2013;10:E107.
47. Centers for Disease Control and Prevention (CDC). Consortium of National Networks to Impact Populations Experiencing Tobacco-Related and Cancer Health Disparities. Atlanta, GA: Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, CDC; 2016. Available at: https://www.cdc.gov/tobacco/about/coop-agreements/national-networks/. Accessed May 9, 2017.
48. Centers for Disease Control and Prevention (CDC). Policies and Practices for Cancer Prevention. Lung Cancer Screening Programs. Atlanta, GA: Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDCl 2015. Available at: http://www.cdc.gov/cancer/ncccp/pdf/lungcancerscreeningprograms.pdf. Accessed May 9, 2017.
49. Hunnibell LS, Slatore CG, Ballard EA. Foundations for lung nodule management for nurse navigators. Clin J Oncol Nurs. 2013;17:525-531.
50. Ellis L, Woods LM, Estève J, Eloranta S, Coleman MP, Rachet B. Cancer incidence, survival and mortality: explaining the concepts. Int J Cancer. 2014;135:1774-1782.
51. Ferlay J, Soerjomataram I, Ervik M, et al. International Agency for Research on Cancer, World Health Organization. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality, and Prevalence Worldwide in 2012. Available at: http://globocan.iarc.fr/Default.aspx. Accessed May 9, 2017.